NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Asentech LLC proudly announces its Gold win at the esteemed 2025 PM360 Pharma Choice Awards in the Professional Website category for its submission of the Viatris® MedConnect portal - a global platform for medical engagement. This prestigious recognition underscores Asentech's commitment to delivering innovative and engaging digital solutions for the life sciences industry.
The Pharma Choice Awards, hosted annually, celebrate the most outstanding creative and strategic achievements in pharmaceutical marketing and digital innovation. Recognizing excellence across multiple categories, these awards highlight industry leaders who push the boundaries of digital engagement, healthcare communications, and brand experiences.
"Our team at Asentech is honored to receive this recognition," said Anil Bhaskar, Managing Partner at Asentech LLC. "Winning Gold at the Pharma Choice Awards affirms our dedication to crafting impactful digital experiences that empower healthcare professionals and drive meaningful engagement. Viatris MedConnect exemplifies our expertise in developing platforms that deliver global, privacy-compliant solutions across diverse markets, while enabling personalized engagement strategies for HCPs."
This Gold win further cements the company's leadership in delivering cutting-edge digital solutions that create a meaningful impact in the healthcare ecosystem.
About Asentech
Asentech leads in digital transformation for Life Sciences brands, offering advanced data and technology solutions to amplify customer engagement across multiple channels through data-driven strategies and omnichannel approaches.
Visit https://www.asentechllc.com/ to learn more about us.
PR Contact: RASHMI KHAIRNAR, rashmi.khairnar@asentech.com
SOURCE: Asentech
View the original press release on ACCESS Newswire
